about
Prevention of infections during primary immunodeficiencyMast cell sarcoma: new cases and literature reviewMastocytosis among elderly patients: A multicenter retrospective French study on 53 patients.SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes.Imported African histoplasmosis in an immunocompetent patient 40 years after staying in a disease-endemic area.A French National Survey on Clotting Disorders in Mastocytosis.Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyAntifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and reviewASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives.Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive.Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature.Mast cell leukemia.Association of mastocytosis with inflammatory joint diseases: a series of 31 patients.Granulocyte colony stimulating factor-induced exacerbation of fungus-related immune restoration inflammatory syndrome: a case of chronic disseminated candidiasis exacerbation.FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis.Rapamycin for refractory acute graft-versus-host disease.Gastrointestinal manifestations in mastocytosis: a study of 83 patients.Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia.A neuropathological study of cerebrovascular abnormalities in a signal transducer and activator of transcription 3-deficient patient.Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency.Invasive Pasteurella multocida sinusitis in a renal transplant patient.Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.Ivory vertebra and systemic mastocytosis.[Anaerobic deep abscesses with unusual location: report of 5 cases].Isolated flushes without permanent, fixed or other skin lesions in patients with systemic mastocytosis: a case series of 9 patients.Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study.Cellulitis Revealing a Cryptococcosis-Related Immune Reconstitution Inflammatory Syndrome in a Renal Allograft Recipient[Infectious complications of immune deficiencies]Midostaurin in Advanced Systemic MastocytosisCutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: A retrospective, single-center study of 21 patients diagnosed using molecular analysisDecreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms
P50
Q27008430-23692CD3-E602-4043-87E9-D686B28E2415Q28071802-14C598BF-C359-4419-8748-57354781D1CDQ33433126-82711AA5-F0CC-41BB-AA90-456A7893FEDAQ33558793-BEDF9D24-E8C4-4F91-AA2C-3AE98BD7A3EBQ34496061-9377ADE8-52B1-497B-B52F-193A3EA4BCF8Q36195456-49F3DD25-7317-4C4A-82F4-83EC362E26D6Q36742242-CBBCD9F1-BE1E-482C-A120-3F3A3E674EF1Q36923083-9523B361-DEFC-477D-9C93-7432F2BA1DFBQ37115777-A3A56778-546D-4C63-A21F-CEDD57E39D2FQ37499442-157EF47D-4037-4016-92D9-89BEE504C67AQ37807108-6599DEFE-FC3A-4005-9E13-1CAF2B6721B8Q38045311-2C00C111-3534-4158-AAA4-DE1BDCB12385Q38058075-82F3B30D-844C-420D-BD92-3B58385BB52BQ38067698-C3829C25-48BF-488A-9276-75365BB0BA0DQ38887197-5DE831FD-F2D8-405D-86A5-A797C12725B5Q38938071-80649F4F-07E1-41C3-83A1-E819444BD43AQ38974374-0AE10646-B71C-48D1-BCAC-A74ECEE8FB46Q40500968-1858A81C-69F4-4197-9802-4F356B6A42D1Q40896987-A76C9BAD-0C5A-44E6-B819-81F521A48BBCQ41206138-3DFDF55F-DF5F-49FE-8E2B-D0E102E986CEQ41954562-CD818AD4-88E1-43D5-9FA4-26EFEABC8620Q42237656-03636BC8-136D-48E1-9E7C-4B5411B2C5EFQ43246106-51D0D006-5DA5-4D76-9E38-B11E27066605Q47925373-6CF9203F-C552-47CE-BCC8-9C2FF88631C3Q47943761-19889A80-110F-4113-B50B-C2D5A728B5CCQ48095776-2B7A5F61-5F83-44D0-AB6C-E302ABF42F8CQ50669764-27F33F3E-FD82-44FA-BF8D-04F5E557672FQ51185308-6F65DDD0-41C5-46ED-9603-6DEF72A97028Q51746464-595F07F9-18FD-4625-A774-313A7E5F751DQ53173527-C6EEC104-2BFA-4880-B9C2-E4B701716AAEQ53854787-8580040C-57FB-4354-8085-49F510F5DD3BQ54299692-3D35743A-F82B-4F2B-9B77-CB1CBF4DE669Q54530545-A26513C3-B04D-48E4-9B58-BD58EA90FE97Q54562253-E3231FCB-31C6-4F5C-859F-94C73EE621D6Q55056945-8518855F-22D5-4583-829B-F81F49E9D229Q56459321-B9D8523B-F6F7-4075-BA63-3668E477462BQ56459333-0F1C0B80-BF92-4A0D-A570-4A11E564D1F8Q56977697-3DE12EC9-D036-4935-8D37-6DBBBBEDBE6FQ57014618-A421ABBC-00A8-4EC0-8642-DD13CDBFC978Q57216636-4603172F-E851-49E6-AFFE-301F44EA7443
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marie-Olivia Chandesris
@ast
Marie-Olivia Chandesris
@en
Marie-Olivia Chandesris
@es
Marie-Olivia Chandesris
@nl
type
label
Marie-Olivia Chandesris
@ast
Marie-Olivia Chandesris
@en
Marie-Olivia Chandesris
@es
Marie-Olivia Chandesris
@nl
prefLabel
Marie-Olivia Chandesris
@ast
Marie-Olivia Chandesris
@en
Marie-Olivia Chandesris
@es
Marie-Olivia Chandesris
@nl
P106
P31
P496
0000-0002-9795-1085